Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT06675123 · RECRUITING
Trial details
- NCT number
- NCT06675123
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-03-08
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.